Position in BMY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,026,317
-$159,142 QoQ
Shares Held
52,522
0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.89%
of 13F equity value
Holder Rank
#694
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AIMZ Investment Advisors, LLC holds $37,637,360 across 11 Drug Manufacturers - General names. BMY ranks #8 (8.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
|
61,319 | $7,747,042 | |
| 2 | AZN |
Astrazeneca PLC
|
27,221 | $5,161,646 | |
| 3 | AMGN |
Amgen Inc
|
12,935 | $4,684,022 | |
| 4 | ABBV |
AbbVie Inc.
|
15,376 | $3,869,216 | |
| 5 | JNJ |
Johnson & Johnson
|
13,954 | $3,543,897 | |
| 6 | MRK |
Merck & Co., Inc.
|
25,475 | $3,273,537 | |
| 7 | GSK |
GSK plc
|
59,214 | $3,103,997 | |
| 8 | BMY |
Bristol Myers Squibb Co
This page
|
52,522 | $3,026,317 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,026,317 | 52,522 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,185,459 | 52,522 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,874,031 | 53,282 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,429,897 | 53,878 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,446,241 | 52,846 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $3,228,383 | 52,933 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $3,003,562 | 53,104 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $2,755,103 | 53,249 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,218,491 | 53,419 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $2,853,582 | 52,620 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $2,694,544 | 52,515 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $2,931,658 | 50,511 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,247,700 | 50,785 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $3,526,631 | 50,882 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $3,725,499 | 51,779 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $3,717,722 | 52,296 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $4,024,713 | 52,269 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $3,816,985 | 52,266 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $3,367,149 | 54,004 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $3,085,774 | 52,151 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,797,285 | 41,863 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $2,642,621 | 41,860 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $2,612,269 | 42,113 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $2,547,734 | 42,258 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $2,519,697 | 42,852 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $2,342,306 | 42,022 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||